Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.37
-1.47 %
$ 399 M
Market Cap
-1.88
P/E
EBS - CASH FROM OPERATIONS
Cash from Operations EBS - Emergent BioSolutions Inc.
-206 M
LAST VALUE
-28.16%
2 YEAR CAGR
-42.79%
5 YEAR CAGR
-12.08%
10 YEAR CAGR